Study of repigmentation patterns and dermatoscopic features in vitiligo treated with various modalities
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-03170-2 ↗Kurz gefasst
Leserbrief in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Apoorva Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India. Hauptthemen laut MEDLINE: Vitiligo, Skin Pigmentation, Dermoscopy. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India.
- Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
- Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, 160012, India. parsad@me.com.
Zitieren
APA
Sharma, A., Arpitha, R., Kumaran, M. S., Prakash, A., & Parsad, D. (2024). Study of repigmentation patterns and dermatoscopic features in vitiligo treated with various modalities. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03170-2
Vancouver
Sharma A, Arpitha R, Kumaran MS, Prakash A, Parsad D. Study of repigmentation patterns and dermatoscopic features in vitiligo treated with various modalities. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03170-2
BibTeX
@article{Sharma2024,
author = {Sharma, Apoorva and Arpitha, R and Kumaran, Muthu Sendhil and Prakash, Ajay and Parsad, Davinder},
title = {Study of repigmentation patterns and dermatoscopic features in vitiligo treated with various modalities},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-03170-2}
}
EUVIMED